Accustem Sciences Shareholders’ Equity Growth & History (ACUT)

Accustem Sciences's shareholders’ equity was −$3.4M for fiscal 2025.

View full Accustem Sciences company overview

Accustem Sciences annual shareholders’ equity history

Accustem Sciences annual shareholders’ equity

Fiscal yearPeriod endedShareholders’ equityChangeGrowth
20252025-12-31−$3.4M−$88,401
20242024-12-31−$3.3M−$1.2M
20232023-12-31−$2.1M−$2.0M
20222022-12-31−$139,550−$790,223
20212021-12-31$650,673

Accustem Sciences shareholders’ equity trends

Between the periods ended 2021-12-31 and 2025-12-31, Accustem Sciences's shareholders’ equity decreased from $650,673 to −$3.4M, a change of −$4.1M. The latest reported quarter, Q2 2026, shows −$4.1M.

About the metric

What shareholders’ equity means

Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.

Calculation and source

SEC-reported shareholders’ equity

TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Accustem Sciences source filings ↗

Community posts

It’s quiet here.

No posts about ACUT yet. Start the conversation.

Write the first post